Comprehensive characterization of DNA variations can help to progress in multiple cancer genomics fields. Next Generation Sequencing (NGS) is currently the most efficient technique to determine a DNA sequence, due to low experiment cost and time compared to the traditional Sanger sequencing. Nevertheless, detection of mutations from NGS data is still a difficult problem, in particular for somatic mutations present in very low abundance like when trying to identify tumor subclonal mutations, tumor-derived mutations in cell free DNA, or somatic mutations from histological normal tissue. The main difficulty is to precisely distinguish between true mutations from sequencing artifacts as they reach similar levels. In this thesis we have studied ...
All domains of science and technology produce large and heterogeneous data. Although a lot of work w...
During meiosis, recombination hotspots host the formation of DNA double-strand breaks (DSBs). DSBs a...
Novel therapeutic approaches are being introduced for genetic muscle diseases such as muscle dystrop...
The recent advance in high-throughput sequencing and genotyping protocols allows rapid investigation...
Une des plus grandes avancées en cancérologie et en génétique au cours des vingt dernières années fû...
Biomarker signatures in cancer are generally defined as a single or a combined alteration of genes a...
Important developments in biotechnologies have moved the paradigm of gene expression analysis from a...
Conventional dose-finding approaches in oncology of phase I clinical trials aim to identify the opti...
MicroRNAs (miRNAs) are small non-coding RNAs that are key players in the regulation of gene expressi...
In oncology, a new paradigm tries to impose itself ; analyzing patient’s tumors, and identifying mol...
CHARGE syndrome (CS) is a rare genetic disease characterized by numerous congenital abnormalities, m...
The spatiotemporal program of DNA replication is regulated during development and altered during can...
As the DNA sequence of the human genome is now completed and available, interest is shifting towards...
Kidney cancer is one of the 10 commonest human cancers. To date, no biomolecular markers are availab...
In many organisms, sexes are determined by sex chromosomes. However, studies have been greatly limit...
All domains of science and technology produce large and heterogeneous data. Although a lot of work w...
During meiosis, recombination hotspots host the formation of DNA double-strand breaks (DSBs). DSBs a...
Novel therapeutic approaches are being introduced for genetic muscle diseases such as muscle dystrop...
The recent advance in high-throughput sequencing and genotyping protocols allows rapid investigation...
Une des plus grandes avancées en cancérologie et en génétique au cours des vingt dernières années fû...
Biomarker signatures in cancer are generally defined as a single or a combined alteration of genes a...
Important developments in biotechnologies have moved the paradigm of gene expression analysis from a...
Conventional dose-finding approaches in oncology of phase I clinical trials aim to identify the opti...
MicroRNAs (miRNAs) are small non-coding RNAs that are key players in the regulation of gene expressi...
In oncology, a new paradigm tries to impose itself ; analyzing patient’s tumors, and identifying mol...
CHARGE syndrome (CS) is a rare genetic disease characterized by numerous congenital abnormalities, m...
The spatiotemporal program of DNA replication is regulated during development and altered during can...
As the DNA sequence of the human genome is now completed and available, interest is shifting towards...
Kidney cancer is one of the 10 commonest human cancers. To date, no biomolecular markers are availab...
In many organisms, sexes are determined by sex chromosomes. However, studies have been greatly limit...
All domains of science and technology produce large and heterogeneous data. Although a lot of work w...
During meiosis, recombination hotspots host the formation of DNA double-strand breaks (DSBs). DSBs a...
Novel therapeutic approaches are being introduced for genetic muscle diseases such as muscle dystrop...